Arterial and Cellular Inflammation in Patients with CKD

Sophie J. Bernelot Moens(Center for Vascular Biology Research), Erik S.G. Stroes(Amsterdam University Medical Centers), Henk A. Marquering(Amsterdam UMC Location University of Amsterdam), Miranda Versloot(Institute of Experimental Medicine), Liffert Vogt(Amsterdam Neuroscience), Julian C. van Capelleveen(Amsterdam University Medical Centers), Fleur M. van der Valk(Western University), Raphaël Duivenvoorden(Radboud University Nijmegen), Jeffrey Kroon(VIB-KU Leuven Center for Cancer Biology), Simone L. Verweij(Center for Vascular Biology Research), Hein J. Verberne
Journal of the American Society of Nephrology
October 31, 2016
10.1681/asn.2016030317
Cited by 64

Related Papers

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
|European Heart Journal|2015|1.4k
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
|European Heart Journal|2022|1.3k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
|European Heart Journal|2014|1.1k